Stay updated on Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Sign up to get notified when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.

Latest updates to the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe Publications section now clarifies that publications are automatically filled from PubMed, and the revision version has been updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check18 days agoChange DetectedRemoved the government funding/operational status notice from the page; the study details and other content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check32 days agoChange DetectedThe update appears to affect only study record metadata (e.g., last update dates and related timestamps), with no changes to core study content such as eligibility criteria, locations, or outcome measures. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check61 days agoChange DetectedUpgraded to version v3.2.0 and added a government funding/operating-status notice; removed the previous v3.1.0 version tag.SummaryDifference2%

- Check68 days agoChange Detected- Updated version from v3.0.2 to v3.1.0. - No other content changes detected.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page now shows revision v3.0.2 instead of v3.0.1, and the 'Back to Top' link was removed; core content such as names, pricing, stock, and time slots remains unchanged.SummaryDifference0.1%

Stay in the know with updates to Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entinostat Plus Pembrolizumab in Advanced Cancers Clinical Trial page.